Improved Overall Survival with 12 Cycles of Single-Agent Paclitaxel Maintenance Therapy following a Complete Response to Induction Chemotherapy in Advanced Ovarian Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|78|5-6|389-393

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.5-6, 2010-08, pp. : 389-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved Survival with Single-Agent Paclitaxel Consolidation/Maintenance Therapy in Advanced Ovarian Carcinoma

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 49-53

Karger

Access to resources Recommend Favorite

Nedaplatin as a Single-Agent Chemotherapy May Support Palliative Therapy for Patients with Adenoid Cystic Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 783-789

Karger

Access to resources Recommend Favorite

Single-Agent Gemcitabine in Previously Untreated Elderly Patients with Advanced Bladder Carcinoma: Response to Treatment and Correlation with the Comprehensive Geriatric

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 27-32

Karger

Access to resources Recommend Favorite

Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 158-165

Karger

Access to resources Recommend Favorite

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 683-688

Karger

Access to resources Recommend Favorite